Literature DB >> 19233447

The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection.

Mir A Ali1, Qingxue Li, Elizabeth R Fischer, Jeffrey I Cohen.   

Abstract

Varicella-zoster virus (VZV) glycoprotein E (gE) interacts with glycoprotein I and with insulin degrading enzyme (IDE), which is a receptor for the virus. We found that a VZV gE deletion mutant could only be grown in cells expressing gE. Expression of VZV gE on the surface of cells did not interfere with VZV infection. HSV deleted for gE is impaired for cell-to-cell spread; VZV gE could not complement this activity in an HSV gE null mutant. VZV lacking the IDE binding domain of gE grew to peak titers nearly equivalent to parental virus; however, it was impaired for cell-to-cell spread and for infectivity with cell-free virus. VZV deleted for a region of gE that binds glycoprotein I could not replicate in cell culture unless grown in cells expressing gE. We conclude that the IDE binding domain is important for efficient cell-to-cell spread and infectivity of cell-free virus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19233447      PMCID: PMC2797441          DOI: 10.1016/j.virol.2009.01.023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  46 in total

1.  The extracellular domain of herpes simplex virus gE is sufficient for accumulation at cell junctions but not for cell-to-cell spread.

Authors:  T Wisner; C Brunetti; K Dingwell; D C Johnson
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins.

Authors:  G Zhou; V Galvan; G Campadelli-Fiume; B Roizman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  The acidic amino-terminal region of varicella-zoster virus open reading frame 4 protein is required for transactivation and can functionally replace the corresponding region of herpes simplex virus ICP27.

Authors:  M Moriuchi; H Moriuchi; S Debrus; J Piette; J I Cohen
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

4.  Herpes simplex virus gE/gI expressed in epithelial cells interferes with cell-to-cell spread.

Authors:  Wendy J Collins; David C Johnson
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

5.  Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells.

Authors:  C Mo; E E Schneeberger; A M Arvin
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.

Authors:  Jennifer Moffat; Hideki Ito; Marvin Sommer; Shannon Taylor; Ann M Arvin
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread.

Authors:  Yoshiaki Yamagishi; Tomohiko Sadaoka; Hironori Yoshii; Pranee Somboonthum; Takayoshi Imazawa; Kazuhiro Nagaike; Keiichi Ozono; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

8.  An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures.

Authors:  Robert G Bennett; Frederick G Hamel; William C Duckworth
Journal:  Diabetes       Date:  2003-09       Impact factor: 9.461

9.  Phosphorylation by the varicella-zoster virus ORF47 protein serine kinase determines whether endocytosed viral gE traffics to the trans-Golgi network or recycles to the cell membrane.

Authors:  T K Kenyon; Jeffrey I Cohen; Charles Grose
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells.

Authors:  Chengjun Mo; Jay Lee; Marvin Sommer; Charles Grose; Ann M Arvin
Journal:  Virology       Date:  2002-12-20       Impact factor: 3.616

View more
  20 in total

1.  Immunogenicity of varicella zoster virus glycoprotein E DNA vaccine.

Authors:  Lidao Bao; Guomin Wei; Hongmei Gan; Xianhua Ren; Ruilian Ma; Y I Wang; Haijun Lv
Journal:  Exp Ther Med       Date:  2016-02-19       Impact factor: 2.447

2.  Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk.

Authors:  Seung-Tae Lee; Paige Bracci; Mi Zhou; Terri Rice; John Wiencke; Margaret Wrensch; Joseph Wiemels
Journal:  Int J Cancer       Date:  2013-10-31       Impact factor: 7.396

3.  Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells.

Authors:  Stefan L Oliver; Marvin H Sommer; Mike Reichelt; Jaya Rajamani; Leonssia Vlaycheva-Beisheim; Shaye Stamatis; Jason Cheng; Carol Jones; James Zehnder; Ann M Arvin
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

4.  Simian varicella virus gene expression during acute and latent infection of rhesus macaques.

Authors:  Christine Meyer; Amelia Kerns; Alex Barron; Craig Kreklywich; Daniel N Streblow; Ilhem Messaoudi
Journal:  J Neurovirol       Date:  2011-11-04       Impact factor: 2.643

5.  Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis.

Authors:  Stefan L Oliver; Edward Yang; Ann M Arvin
Journal:  Curr Clin Microbiol Rep       Date:  2016-09-09

6.  Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses.

Authors:  Tadahiro Suenaga; Takeshi Satoh; Pranee Somboonthum; Yasushi Kawaguchi; Yasuko Mori; Hisashi Arase
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

7.  Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.

Authors:  Barbara Berarducci; Jaya Rajamani; Leigh Zerboni; Xibing Che; Marvin Sommer; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

8.  Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability.

Authors:  Qingxue Li; Mir A Ali; Kening Wang; Dean Sayre; Frederick G Hamel; Elizabeth R Fischer; Robert G Bennett; Jeffrey I Cohen
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

9.  Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis.

Authors:  Li Wang; Marvin Sommer; Jaya Rajamani; Ann M Arvin
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

10.  Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum.

Authors:  J E Carpenter; W Jackson; G A de Souza; L Haarr; C Grose
Journal:  J Virol       Date:  2009-10-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.